Tarah Jean Ballinger

16PUBLICATIONS

110CO-AUTHORS

Epidemiological modellingMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|May 30, 2026

Impact of patient-reported taxane-induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG-ACRIN EAZ171.

|Apr 14, 2026

A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancer.

Kathy D Miller, Alexandra Thomas, Sandra Althouse

|Jan 23, 2025

Abdominal visceral and subcutaneous adipose tissue associations with postmenopausal breast cancer incidence.

Jennifer W Bea, Heather M Ochs-Balcom, Celina I Valencia

|Oct 25, 2024

Randomized Controlled Trial of Acceptance and Commitment Therapy for Fatigue Interference With Functioning in Metastatic Breast Cancer.

Catherine E Mosher, Shieun Lee, Elizabeth L Addington

|Oct 08, 2024

Discerning the impact of ctDNA detection on patient decision-making in early-stage breast cancer.

Tarah J Ballinger, Mary Lou Smith, Elda Railey

|Jul 19, 2024

Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial).

Adrienne G Waks, Emily L Chen, Noah Graham

Pageof 3

Frequent Collaborators

Bryan P Schneider

Kathy D Miller

Fei Shen

Anna Maria V Storniolo

3 joint publications

Vandana G Abramson

3 joint publications

Claudine Isaacs

2 joint publications

Christopher Gallagher

2 joint publications

Nawal Kassem

2 joint publications

Casey L Bales

2 joint publications

Alexandra Thomas

Frequent Collaborators

Bryan P Schneider

Kathy D Miller

Fei Shen

Anna Maria V Storniolo